| Pitavastatin | hsa00330 | Arginine and proline metabolism | 4.86E-02 | 1 | P17707 | AMD1 | More | |
| Pitavastatin | hsa00564 | Glycerophospholipid metabolism | 2.28E-02 | 3 | Q9Y259, P23743, Q3LIE5 | CHKB, DGKA, ADPRM | More | |
| Pitavastatin | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | |
| Pitavastatin | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | |
| Pitavastatin | hsa00630 | Glyoxylate and dicarboxylate metabolism | 9.21E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | |
| Pitavastatin | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | |
| Pitavastatin | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
| Pitavastatin | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
| Pitavastatin | hsa03040 | Spliceosome | 1.08E-02 | 7 | O43143, P08579, Q07955, P84103, Q13243, P11142, O75643 | DHX15, SNRPB2, SFRS1, SFRS3, SFRS5, HSPA8, ASCC3L1 | More | |
| Pitavastatin | hsa03050 | Proteasome | 1.21E-02 | 1 | P28074 | PSMB5 | More | |
| Pitavastatin | hsa04012 | ErbB signaling pathway | 4.75E-02 | 3 | P16333, P19174, P01106 | NCK1, PLCG1, MYC | More | |
| Pitavastatin | hsa04020 | Calcium signaling pathway | 4.45E-02 | 3 | P0DP24, P51828, P23634 | CALM2, ADCY7, ATP2B4 | More | |
| Pitavastatin | hsa04024 | cAMP signaling pathway | 3.79E-02 | 3 | P51828, P0DP24, P23634 | ADCY7, CALM2, ATP2B4 | More | |
| Pitavastatin | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | |
| Pitavastatin | hsa04062 | Chemokine signaling pathway | 1.83E-02 | 8 | P25024, P25025, P09341, P19875, P42338, P19174, P63218, P50151 | CXCR1, CXCR2, CXCL1, CXCL2, PIK3CB, PLCG1, GNG5, GNG10 | More | |
| Pitavastatin | hsa04064 | NF-kappa B signaling pathway | 2.15E-02 | 7 | P14778, P19174, Q04759, P06239, P09341, P19875, Q06643 | IL1R1, PLCG1, PRKCQ, LCK, CXCL1, CXCL2, LTB | More | |
| Pitavastatin | hsa04071 | Sphingolipid signaling pathway | 2.14E-02 | 3 | Q13510, Q13362, Q9UQC2 | ASAH1, PPP2R5C, GAB2 | More | |
| Pitavastatin | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | |
| Pitavastatin | hsa04114 | Oocyte meiosis | 8.69E-03 | 4 | P0DP24, P51828, P27348, Q13362 | CALM2, ADCY7, YWHAQ, PPP2R5C | More | |
| Pitavastatin | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | |
| Pitavastatin | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | |
| Pitavastatin | hsa04217 | Necroptosis | 2.34E-02 | 4 | P01375, P48023, Q14765, Q99878 | TNF, FASLG, STAT4, H2AC14 | More | |
| Pitavastatin | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.06E-02 | 4 | P51828, Q13362, P0DP24, P23634 | ADCY7, PPP2R5C, CALM2, ATP2B4 | More | |
| Pitavastatin | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | |
| Pitavastatin | hsa04613 | Neutrophil extracellular trap formation | 1.73E-02 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
| Pitavastatin | hsa04640 | Hematopoietic cell lineage | 1.37E-02 | 7 | P14778, P27930, P11215, P25063, P07766, P01732, P09564 | IL1R1, IL1R2, ITGAM, CD24, CD3E, CD8A, CD7 | More | |
| Pitavastatin | hsa04650 | Natural killer cell mediated cytotoxicity | 2.48E-03 | 8 | P19174, P06239, O60880, P20963, P42338, Q13241, P26718, O14931 | PLCG1, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3 | More | |
| Pitavastatin | hsa04658 | Th1 and Th2 cell differentiation | 1.62E-05 | 9 | Q04759, P07766, P20963, P19174, P06239, P42224, Q9UL17, P14784, Q13761 | PRKCQ, CD3E, CD247, PLCG1, LCK, STAT1, TBX21, IL2RB, RUNX3 | More | |
| Pitavastatin | hsa04659 | Th17 cell differentiation | 2.08E-04 | 10 | Q04759, P19174, P06239, P42224, P14784, P14778, Q9UL17, P08238, P07766, P20963 | PRKCQ, PLCG1, LCK, STAT1, IL2RB, IL1R1, TBX21, HSP90AB1, CD3E, CD247 | More | |
| Pitavastatin | hsa04660 | T cell receptor signaling pathway | 3.37E-03 | 8 | Q04759, P42338, P19174, P07766, P20963, P01732, Q13191, P06239 | PRKCQ, PIK3CB, PLCG1, CD3E, CD247, CD8A, CBLB, LCK | More | |
| Pitavastatin | hsa04664 | Fc epsilon RI signaling pathway | 4.75E-02 | 3 | P07948, P19174, P09917 | LYN, PLCG1, ALOX5 | More | |
| Pitavastatin | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | |
| Pitavastatin | hsa04727 | GABAergic synapse | 3.40E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | |
| Pitavastatin | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.24E-03 | 5 | P14778, P19174, P42338, P24723, Q04759 | IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQ | More | |
| Pitavastatin | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | |
| Pitavastatin | hsa04925 | Aldosterone synthesis and secretion | 1.32E-02 | 3 | P51828, P0DP24, P23634 | ADCY7, CALM2, ATP2B4 | More | |
| Pitavastatin | hsa04932 | Non-alcoholic fatty liver disease | 2.74E-02 | 3 | P01375, P49841, P48023 | TNF, GSK3B, FASLG | More | |
| Pitavastatin | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
| Pitavastatin | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 2.09E-02 | 2 | P23634, P62491 | ATP2B4, RAB11A | More | |
| Pitavastatin | hsa04970 | Salivary secretion | 3.20E-03 | 3 | P51828, P23634, P0DP24 | ADCY7, ATP2B4, CALM2 | More | |
| Pitavastatin | hsa04972 | Pancreatic secretion | 4.94E-03 | 3 | P23634, P51828, P62491 | ATP2B4, ADCY7, RAB11A | More | |
| Pitavastatin | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | |
| Pitavastatin | hsa05017 | Spinocerebellar ataxia | 2.43E-02 | 1 | P28074 | PSMB5 | More | |
| Pitavastatin | hsa05034 | Alcoholism | 1.19E-04 | 7 | Q13547, P63218, P50151, Q93077, P62807, O60814, P68431 | HDAC1, GNG5, GNG10, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
| Pitavastatin | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | |
| Pitavastatin | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | |
| Pitavastatin | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | |
| Pitavastatin | hsa05145 | Toxoplasmosis | 3.59E-02 | 5 | P42224, P09917, Q13751, P11142, Q13651 | STAT1, ALOX5, LAMB3, HSPA8, IL10RA | More | |
| Pitavastatin | hsa05146 | Amoebiasis | 2.21E-04 | 8 | P09341, P19875, P14778, P27930, P42338, P11215, P05089, P12814 | CXCL1, CXCL2, IL1R1, IL1R2, PIK3CB, ITGAM, ARG1, ACTN1 | More | |
| Pitavastatin | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | |
| Pitavastatin | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.79E-02 | 6 | P42224, P63218, P50151, P19174, P07948, P01106 | STAT1, GNG5, GNG10, PLCG1, LYN, MYC | More | |
| Pitavastatin | hsa05169 | Epstein-Barr virus infection | 1.43E-02 | 8 | P01106, Q13547, P07948, P30101, Q13761, O75293, P42224, P07766 | MYC, HDAC1, LYN, PDIA3, RUNX3, GADD45B, STAT1, CD3E | More | |
| Pitavastatin | hsa05200 | Pathways in cancer | 5.69E-03 | 14 | Q13751, P08238, P42224, P19174, P01106, P43246, P20585, Q13547, P49767, P63218, P50151, P78417, O75293, P14784 | LAMB3, HSP90AB1, STAT1, PLCG1, MYC, MSH2, MSH3, HDAC1, VEGFC, GNG5, GNG10, GSTO1, GADD45B, IL2RB | More | |
| Pitavastatin | hsa05203 | Viral carcinogenesis | 6.58E-03 | 7 | P07948, P29083, Q13547, Q15283, P12814, P62807, O60814 | LYN, GTF2E1, HDAC1, RASA2, ACTN1, HIST1H2BC, H2BC12 | More | |
| Pitavastatin | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
| Pitavastatin | hsa05206 | MicroRNAs in cancer | 3.79E-02 | 6 | P30304, P09493, P01106, Q9Y4H2, Q13547, P19174 | CDC25A, TPM1, MYC, IRS2, HDAC1, PLCG1 | More | |
| Pitavastatin | hsa05231 | Choline metabolism in cancer | 1.08E-02 | 4 | O15245, Q9Y259, P19174, P23743 | SLC22A1, CHKB, PLCG1, DGKA | More | |
| Pitavastatin | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.27E-03 | 6 | P42338, P19174, P07766, P20963, P06239, Q04759 | PIK3CB, PLCG1, CD3E, CD247, LCK, PRKCQ | More | |
| Pitavastatin | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
| Pitavastatin | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
| Pitavastatin | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
